Related Experiment Video
Updated: Jun 20, 2026

Psychophysical Tracking Method to Measure Taste Preferences in Children and Adults
Published on: July 16, 2016
Pediatric sweet syndrome: case report and literature review
1Department of Dermatology, University Hospital of North Staffordshire, Stoke-on-Trent, United Kingdom. james_halpern@hotmail.com
Insights
Sweet syndrome in children typically follows an infection. Young children under 3 rarely have associated cancers, unlike older children, and respond well to steroids. Serious complications can occur.
Area of Science:
- Pediatric Dermatology
- Hematology
- Immunology
Background:
- Sweet syndrome, also known as acute febrile neutrophilic dermatosis, is an inflammatory condition.
- It is characterized by fever, neutrophilia, and a distinctive skin rash.
- While often associated with hematologic malignancies in adults, its presentation and associations in children differ.
Purpose of the Study:
- To describe a case of pediatric Sweet syndrome following an upper respiratory tract infection.
- To conduct a comprehensive literature review of pediatric Sweet syndrome cases.
- To analyze age-related differences in presentation, associations, and outcomes of pediatric Sweet syndrome.
Main Methods:
- Case report of an 18-month-old boy with Sweet syndrome.
- Systematic literature review of 66 reported pediatric Sweet syndrome cases.
- Comparative analysis of cases based on age (under vs. over 3 years).
Main Results:
- The case presented with typical Sweet syndrome features post-infection and responded to oral prednisolone without evidence of malignancy.
- Literature review identified 66 pediatric cases.
- Cases under 3 years showed male predominance and no malignancy association, contrasting with older children who had equal sex distribution and strong links to myeloid malignancies.
Conclusions:
- Pediatric Sweet syndrome can present typically after infections and is treatable with corticosteroids.
- Age is a critical factor in the clinical presentation and associated risks of Sweet syndrome in children.
- While generally less severe than in adults, pediatric Sweet syndrome carries significant risks, particularly cardiovascular involvement, with a notable mortality rate.
Abstract:
We report on an 18-month-old boy with a typical presentation of Sweet syndrome following an upper respiratory tract illness. No evidence of hematologic malignancy was found and he was successfully treated with oral prednisolone. A comprehensive literature review has summarized the features of pediatric Sweet syndrome from 66 reported cases. Cases occurring under the age of 3 years had a male predominance and no association with malignancy, whereas cases over the age of 3 years had an equal sex distribution and were strongly associated with myeloid line hematologic malignancies. Identified complications were serious with an overall mortality of 9% rising to 40% with cardiovascular involvement.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Excretion
Taste Buds and Receptors
